Ready to contact us for a consultation about your condition and our medical services? The staff of our Global Patient Services is ready to help. Please select the appropriate button to get started.

Sheba Begins Clinical Trial for INSPIRA Technologies’ Innovative HYLA Blood Sensor

Blood Sensor
The new non-invasive technology to monitor blood oxygen levels will be applied in operating rooms at Sheba’s Department of Cardiac Surgery

Sheba Medical Center will begin a new clinical trial for the HYLA blood sensor developed by INSPIRA Technologies. The trial, led by Dr. Yigal Kassif, Sheba’s principal investigator, will take place in the operating rooms of Sheba’s Department of Cardiac Surgery. 

“Sheba Medical Center focuses on quality clinical research programs of key medical advancements to improve patient outcomes worldwide. INSPIRA Technologies’ HYLA blood sensor technology has significant potential to enhance real-time patient monitoring,” Dr. Kassif said. 

The HYLA blood sensor provides surgeons with real-time oxygen measurements by continuously monitoring blood gas levels. Doctors can then be alerted to sudden changes as soon as they occur and take immediate action – improving treatment outcomes as well as reducing the risk of complications.

The study aims to evaluate the HYLA blood sensor in an operating room setting, specifically when used to monitor patients undergoing open heart surgery while connected to a cardiopulmonary bypass machine. “The HYLA blood sensor is designed for multiple hospital settings, both inside and outside the operating room,” says the CEO of INSPIRA Technologies, Dagi Ben-Noon. In the future, HYLA will be integrated with INSPIRA’s Augmented Respiration Technology (ART) to replace traditional mechanical ventilation systems with non-invasive oxygen support. 

As Israel’s leading medical research facility, Sheba is dedicated to promoting healthcare innovation through technologies such as the HYLA blood sensor, which will hopefully facilitate a future where medical care is more accessible, effective, and safe.

Sheba Ranked Among the Top 10 Hospitals in the World by Newsweek
We are pleased to announce that for the sixth consecutive year, Sheba has been recognized as one of the best hospitals in the world by…
Read More
Doctor analyzing hemophilia blood with a microscope. The focus of the shot is on the blood.
Breakthrough Hemophilia Treatment by Prof. Gili Kenet Empowers Boy's Dream
Prof. Gili Kenet, a renowned pediatric hematologist at Sheba’s National Hemophilia Center and an esteemed professor at the Sackler School of Medicine, unveiled a groundbreaking…
Read More
Text "SCIENCE DOSE" with a magnifying glass next to it zooming in on cells and viruses. Additional elements include a syringe, microscope, and blood cells.
Navigating Retinoblastoma: Expert Analysis by Prof. Didi Fabian
Prof. Didi Fabian, a senior ocular oncologist at Sheba’s Goldschleger Eye Institute and Director of Sheba Global Ophthalmology, recently delved into retinoblastoma, an eye cancer…
Read More